Breakthrough device design talks patients and caregivers through the injection process Sanofi (EURONEXT: SAN and NYSE: SNY) have announced that the U.S. Food and Drug Administration (FDA) has approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Auvi-Q is the first-and-only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process...
Realtime Related Tweets
bishop eddie long madonna give me all your luvin video roseanne barr president green party day 26 gronkowski new hunger games trailer
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.